Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma

International Journal of Biological Sciences

Volumn 11, Issue 1, 2015, Pages 1-10

  He, Qianting ^a   Liu, Zhonghua ^a   Zhao, Tingting ^a   Zhao, Luodan ^a   Zhou, Xiaofeng ^b   Wang, Anxun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Bmi1; Cancer stem like cell; invasion; migration; prognosis; Tongue squamous cell carcinoma

Indexed keywords

BMI1 PROTEIN; BMI1 PROTEIN, HUMAN; LUCIFERASE;

ANALYSIS OF VARIANCE; CELL MOTION; CHROMATIN IMMUNOPRECIPITATION; DRUG SCREENING; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR INVASION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CHROMATIN IMMUNOPRECIPITATION; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUCIFERASES; NEOPLASM INVASIVENESS; POLYCOMB REPRESSIVE COMPLEX 1; PROGNOSIS; TONGUE NEOPLASMS; TUMOR STEM CELL ASSAY;

EID: 84909946156     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.10405     Document Type: Article

References (40)

1. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359:1143-54.
2. Zou B, Sun S, Qi X, et al. Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma. Mol Med Rep. 2012;5:1116-20.
3. Rastogi P. Emergence of cancer stem cells in head and neck squamous cell carcinoma: A therapeutic insight with literature review. Dent Res J (Isfahan). 2012;9:239-44.
4. Ailles L, Prince M. Cancer stem cells in head and neck squamous cell carcinoma. Methods Mol Biol. 2009;568:175-93.
5. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104:973-8.
6. Chinn SB, Darr OA, Peters RD, et al. The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure. Front Endocrinol (Lausanne). 2012; 3:90.
7. Proctor E, Waghray M, Lee CJ, et al. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma. PLoS One. 2013;8:e55820.
8. Huang R, Cheung NK, Vider J, et al. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. Faseb J. 2011;25:4138-49.
9. Tsai LL, Yu CC, Chang YC, et al. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol Med. 2011;40:621-8.
10. Seo E, Basu-Roy U, Zavadil J, et al. Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage. Mol Cell Biol. 2011;31:4593-608.
11. Feng JQ, Xu ZY, Shi LJ, et al. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer. J Oral Pathol Med. 2013;42:148-53.
12. Li Z, Wang Y, Yuan C, et al. Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. Lab Invest. 2014; doi: 10.1038/labinvest.
13. Chou CH, Yang NK, Liu TY, et al. Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer. Cancer Res. 2013;73:953-66.
14. Liu W, Feng JQ, Shen XM, et al. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer. 2012;118:1693-700.
15. Ma L, Wang H, Yao H, et al. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma. Ann Diagn Pathol. 2013;17:327-30.
16. Yu CC, Lo WL, Chen YW, et al. Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells. J Oncol. 2011; doi: 10.1155/2011/609259.
17. Hayry V, Makinen LK, Atula T, et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer. 2010;102:892-7.
18. den Hollander J, Rimpi S, Doherty JR, et al. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood. 2010;116:1498-505.
19. Ozawa N, Shichiri M, Fukai N, et al. Regulation of adrenomedullin gene transcription and degradation by the c-myc gene. Endocrinology. 2004;145:4244-50.
20. Bretones G, Acosta JC, Caraballo JM, et al. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. J Biol Chem. 2011;286:9815-25.
21. Wang HB, Liu GH, Zhang H, et al. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma. Febs J. 2013;280:2929-44.
22. Ye H, Wang A, Lee BS, et al. Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics Proteomics. 2008;5:85-94.
23. Liu X, Wang A, Lo Muzio L, et al. Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma. BMC Cancer. 2010;10:365.
24. Liu Z, Li S, Cai Y, et al. Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med. 2012;53:44-50.
25. Ding X, Zhang N, Cai Y, et al. Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol Oncol. 2012;6:73-80.
26. Wang A, Liu X, Sheng S, et al. Dysregulation of heat shock protein 27 expression in oral tongue squamous cell carcinoma. BMC Cancer. 2009;9:167.
27. Li J, Gong LY, Song LB, et al. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol. 2010;176:699-709.
28. He Q, Zhou X, Li S, et al. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway. Biochim Biophys Acta. 2013;1830:5258-66.
29. Yao CJ, Lai GM, Yeh CT, et al. Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ beta -Catenin Signaling and Apoptosis Induction. Evid Based Complement Alternat Med. 2013;2013:146136.
30. Wang A, Alimova IN, Luo P, et al. Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation. Faseb J. 2010;24:833-43.
31. Chen H, Zhou L, Wan G, et al. BMI1 promotes the progression of laryngeal squamous cell carcinoma. Oral Oncol. 2011;47:472-81.
32. Kang MK, Kim RH, Kim SJ, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 2007;96:126-33.
33. Major AG, Pitty LP, Farah CS. Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int. 2013;2013:319489.
34. Chen YC, Chang CJ, Hsu HS, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer- derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol. 2010;46:158-65.
35. Zhou X, Temam S, Oh M, et al. Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia. 2006;8:925-32.
36. Yanamoto S, Kawasaki G, Yamada S, et al. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncol. 2011;47:855-60.
37. Lim W, Choi H, Kim J, et al. Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. J Mol Histol. 2014; doi 10.1007/s10735-014-95 84-1
38. Wang C, Liu X, Huang H, et al. Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma. Int J Cancer. 2012;130:2249-58.
39. Fujioka Y, Taira T, Maeda Y, et al. MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer. J Biol Chem. 2001;276:45137-44.
40. Guney I, Wu S, Sedivy JM. Reduced c-Myc signaling triggers telomere- independent senescence by regulating Bmi-1 and p16(INK4a). Proc Natl Acad Sci USA. 2006;103:3645-50.